Data as of Nov 26
| +0.03 / +0.63%|
The 3 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +46.44% increase from the last price of 4.78.
The current consensus among 4 polled investment analysts is to Hold stock in ChemoCentryx Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.